health

The Barcelona-based Vall d’Hebron Research Institute (VHIR) has identified two proteins that block the metastasis of rhabdomyosarcoma, a type of cancer that represents 8% of this sort of illness in children. These two proteins are related to cellular proliferation and growth as well as having the capacity to migrate to other organs. The study opens the door to the development of new treatments targeting these two proteins. The study was funded by the foundation of the Catalan Public TV Broadcaster and it has been published in the British Journal of Cancer (BJC).

Scientists from the Colorectal Cancer Laboratory at the Barcelona Institute of Biomedical Research (IRB) have discovered the essential process that allows colon cancer cells to metastasise. They have concluded that tumour cells need to form alliances with healthy cells in order to be able to colonise other organs. Tumour cells can survive in the transition period during the metastasis process thanks to a protein (interleukin-11), which is produced by healthy cells that are exposed to another protein (TGF-beta) present in the tumour’s microenvironment. This discovery may lead to new treatments and diagnostic proceedings for colon cancer patients. A test to predict relapse cases and target treatments is likely to be ready in 5 years. The study has been published by the prestigious journal Cancer Cell.

For the first time in the world, Barcelona’s Vall d’Hebron Hospital removes two tumours through the body’s natural holes without the support of laparoscopy. This technique allows the patient to recover much quicker, since there are no external wounds to cicatrise. They have successfully removed a colon tumour and a stomach one, from two different patients who had recovered without complications.

Chemists in Catalonia had called to go on strike on Thursday because the Catalan Government owed them two payments for publicly funded drugs. According to the Catalan Government, the payments were delayed as they depended on receiving the funds from the Spanish Government’s Liquidity Fund. The Spanish Government announced this week it was transferring €99 million to the Catalan Government to pay the chemists. However, on Wednesday the chemists decided to maintain Thursday’s strike “as a warning signal” for the uncertainty on future payments and because they have not received yet the promised payment.

A study developed by researchers from Barcelona’s Center of Regenerative Medicine and California’s Gene Expression Laboratory of the Salk Institute identified a mutation in the nucleus of human neural stem cells that is linked to Parkinson’s, which may help to diagnose the disease and open a new field for targeted treatments. The prestigious journal ‘Nature’ published the study, which could also help to explain why the Parkinson’s disease is often associated with clinical depression and anxiety. The Center of Regenerative Medicine in Barcelona is directed by Juan Carlos Izpisúa, who participated in the study; it is located in the Barcelona Biomedical Research Park, next to the Hospital del Mar.

FC Barcelona and the European Commission join forces to help millions of Europeans to give up smoking. The campaign aims at helping 28 million people giving up tobacco. “With this joint action, we aim to help football fans all over Europe to retake control over their health and their lives, encouraging them to be as passionate and committed to their own health as they are to good football” explained FC Barcelona’s President, Sandro Rosell.

The decision by Spanish Government to restrict access to the public healthcare system could leave 600,000 people in Catalonia (8% of the population) without primary and specialised medical attention. 180,000 of these people would be foreigners. The Catalan Minister for Health, Boi Ruiz, explained that the measure aims to guarantee the universal access to healthcare to all the population, independent of their legal status, but at the same time avoid healthcare tourism.

Compared to a year ago, the Catalan Healthcare System spent 24.6% less last July than in the same month of 2011. In July 2011, Catalonia spent €143.52 million on pharmaceutical products while it spent €108.10 million last month, when the drug prescription fee began and citizens started to pay a greater share of the cost of prescription drugs. Furthermore, drug prescriptions fell by 20%. In the whole of Spain, pharmaceutical spending also decreased by 24% last July, compared to a year ago.

The Spanish Social Security has published the list with the 417 drugs that from September will no longer be subsidised in order to reduce public spending and meet deficit targets. Most of them are some of the most consumed medicines for minor symptoms, such as heartburn, muscle pain, or diarrhoea. Since the measure is not popular among doctors, the Catalan Health Minister, Boi Ruiz, said that more expensive drugs with similar effects but not included in the list may now be prescribed, which would increase pubic healthcare spending instead of reducing it.

The Catalan Government will allow universal access to community health centres, despite the Spanish Government’s decision. Autonomous Communities are those managing the public healthcare system. After announcing that immigrants would not be able to access the service without contributing to the Social Security system, the Spanish Government is now preparing formulas allowing them to continue accessing the public healthcare system if they pay the fee. The Spanish Health, Social Services and Equality has confirmed that foreign people less than 65 years old will pay €710 per year and those older will pay €1,860. Access will be free in emergencies as well as for pregnant women and minors.

Catalan citizens will have to pay €1 for every medical prescription, with a maximum of €61 per year. 127,000 people will not have to pay the tax for social reasons. This measure approved by the Catalan Government aims to reduce healthcare spending by moderating the purchase of medicines, the final goal being reducing the public deficit.

Following the advice of the Catalan Council for Constitutional Guarantees (CGE), the Catalan Executive will appeal the Spanish Government’s decree to save €7 billion in healthcare this year. However, it will continue implementing the decree until a judicial decision is made. According to the CGE, the decree violates 3 Spanish Constitution articles and 3 others from the Catalan Statute of Autonomy. The decree does not guarantee equality among all citizens, since it limits access to public healthcare. In addition, it invades the Catalan Government’s powers. Left-wing Catalan parties were the first to ask for CGE’s opinion, since they consider the new decree violates basic social rights.

The centre received the ‘Gold Level Award’ from the Global Network for Tobacco Health Care Services, thanks to its fight against the effects of smoking. The jury emphasised the training given to both hospital workers and patients in order to give up smoking and the achievement of a strict non-smoking area in this health centre’s facilities. Only ten hospitals around the world have this distinction, among them another Catalan institution: Sant Joan de Déu Hospital in Manresa, in Central Catalonia.

The Catalan Government has rejected the Spanish Executive’s initiative to limit public healthcare to foreign nationals without a legalised residence status. The Spanish Government proposed that irregular immigrants would only have access to emergency rooms and obstetrics services, but not to regular treatments and consultations. The Catalan Health Minister, Boi Ruiz, confirmed on Friday that in Catalonia, all foreign residents, independent of their legal status, would have free access to the public health system for “solidarity” principles but also “for public health reasons”. Besides the ethical issue, experts had warned about infectious diseases that could have increased because of having groups of people excluded from the health system.

This world important discovery should open new paths to develop new drugs and to ultimately find a vaccine against HIV/AIDS. The finding has been published in the international journal PLoS Biology. The study has been funded by the Spanish Government, the Catalan Government, La Caixa savings bank, Barcelona’s Hospital Clínic and Esteve Labs.